首页> 外文学位 >Pathogenesis and therapy of ocular microbial infections.
【24h】

Pathogenesis and therapy of ocular microbial infections.

机译:眼部微生物感染的发病机理和治疗。

获取原文
获取原文并翻译 | 示例

摘要

Staphylococcus aureus and Pseudomonas aeruginosa are two leading causes of severe ocular infections. Damage to ocular tissues is mediated by S. aureus pore-forming toxin, alpha-toxin, or P. aeruginosa secreted proteases. Frequently the antibiotic therapy of S. aureus or P. aeruginosa infection reduces the number of bacteria present, but does not arrest tissue damage mediated by the toxin or protease's action.;The studies undertaken herein analyze: (1) a new model of experimental S. aureus conjunctivitis in a rabbit; (2) a chemical inhibitor to the potent corneal toxin, alpha-toxin; (3) the effectiveness of a new formulation of antibiotic-corticosteroid combination therapy; (4) the effect of the host defense molecule surfactant protein D (SPD) during P. aeruginosa keratitis; (5) a new approach to develop antibody to an important corneal virulence factor, protease IV; and (6) the effect of P. aeruginosa proteases on rabbit tears.;The results show that: (1) degradation a new model of S. aureus experimental conjunctivitis was established, for the analysis of bacterial pathogenesis and the effectiveness of new antibiotics or anti-inflammatory drugs; (2) CD-Cholesterol inhibits the action of alpha-toxin in vitro and topical application of CD-Cholesterol significantly reduces the pathologic effects of S. aureus keratitis without affecting growth of bacteria; (3) in terms of bacterial killing, the combination of tobramycin and dexamethasone in a new vehicle with xanthan gum was superior to these drugs in a standard vehicle; (4) SPD is an important host defense molecule during P. aeruginosa keratitis---mice deficient in SPD experienced significantly more pathology and bacterial growth as compared to mice with functional SPD; (5) antibody to a recombinant form of PIV was obtained after primary immunization, but this antibody was not highly reactive to native PIV; and (6) rabbit tears incubated with P. aeruginosa protease IV (PIV) or alkaline protease underwent massive protein.;These studies evaluated the pathogenesis and therapy of ocular infection and show that SPD and tears are important host defenses against P. aeruginosa infection and that new therapies can limit the damage mediated by ocular infection.
机译:金黄色葡萄球菌和铜绿假单胞菌是严重眼部感染的两个主要原因。眼组织的损伤是由金黄色葡萄球菌的孔形成毒素,α-毒素或铜绿假单胞菌分泌的蛋白酶介导的。通常,金黄色葡萄球菌或铜绿假单胞菌感染的抗生素治疗可减少存在的细菌数量,但不能阻止毒素或蛋白酶作用介导的组织损伤。;本文进行的研究分析:(1)实验性S的新模型兔子的金黄色结膜炎; (2)一种有效的角膜毒素α-毒素的化学抑制剂; (3)抗生素-糖皮质激素联合治疗新配方的有效性; (4)铜绿假单胞菌角膜炎中宿主防御分子表面活性剂蛋白D(SPD)的作用; (5)开发针对重要角膜毒性因子蛋白酶IV的抗体的新方法;结果表明:(1)降解建立了金黄色葡萄球菌实验性结膜炎的新模型,用于分析细菌的发病机理以及新抗生素或抗生素的有效性。抗炎药; (2)CD-胆固醇在体外抑制α-毒素的作用,局部应用CD-胆固醇可显着降低金黄色葡萄球菌性角膜炎的病理作用,而不会影响细菌的生长; (3)就细菌杀灭而言,新载体中的妥布霉素和地塞米松与黄原胶的结合优于标准载体中的这些药物; (4)SPD是铜绿假单胞菌角膜炎期间的重要宿主防御分子-与SPD正常的小鼠相比,SPD缺乏的小鼠的病理学和细菌生长明显增加; (5)在初次免疫后获得了针对PIV的重组形式的抗体,但是该抗体对天然PIV的反应性不高。 (6)用铜绿假单胞菌蛋白酶IV(PIV)或碱性蛋白酶孵育的兔眼泪中含有大量蛋白质。这些研究评估了眼部感染的发病机理和治疗方法,并表明SPD和眼泪是抵抗铜绿假单胞菌感染和感染的重要宿主防御物。新疗法可以限制眼部感染介导的损害。

著录项

  • 作者

    McCormick, Clare.;

  • 作者单位

    The University of Mississippi Medical Center.;

  • 授予单位 The University of Mississippi Medical Center.;
  • 学科 Health Sciences Ophthalmology.;Biology Microbiology.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 206 p.
  • 总页数 206
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号